Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero in Asplenic Patients
NCT06025487Phase 2Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group B vaccine in meningococcal group B infection (MenB), sponsored by Medical University of Vienna. Started Mar 2024; status: recruiting.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal group B infection (MenB)
Beyond the preview
Go deeper on NCT06025487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025487.